Apr. 21 at 5:50 PM
$TRAW
Origins: Sirenia Capital Management was launched by veteran portfolio manager Alex Silverstein, who spun out his healthcare trading team from Point72 Asset Management, where he had been one of its most successful portfolio managers for roughly 13 years.
Point72 provided its largest-ever initial backing to Sirenia, committing hundreds of millions of dollars — which could translate into multiple billions in buying power when leverage is included. This surpassed the
$200 million Point72 provided to Gabe Plotkin when he launched Melvin Capital Management in 2015.
Sirenia invests primarily in public and private equity positions in healthcare and biotechnology companies, and may use derivatives and index-related instruments for hedging and risk management purposes.
Sirenia essentially a high-profile, healthcare-specialist hedge fund — newly launched but immediately well-capitalized, making its involvement in the TRAWS Pharma PIPE a natural fit given TRAW's antiviral drug pipeline.
